In this episode, Eshika Phadke and Tanya Kukade, members of the Pharmaceutical and Lifesciences Practice at Nishith Desai Associates discuss the developments surrounding the possibility of bringing nutraceuticals within the drug regulators control. They further discuss the reasons which have sparked off this debate and the potential implications of this change.

In this episode, Dr. Milind Antani and Eshika Phadke discuss recent trends in the booming Indian healthcare industry, and how hospitals can use legal and regulatory compliances as a tool to not only mitigate risk, but also optimise healthcare quality, patient safety and the reputation of the organisation.

In this episode, Dr. Milind Antani and Tanya Kukade discuss the growing reliance on public procurement in the pharmaceutical and medical devices sector in India. They discuss the recent developments in regulatory framework surrounding public procurement in India and delve into the key issues faced by the industry in satisfying the unique requirements under the public procurement orders.

In this episode, Dr. Milind Antani sets the pace for a series of podcasts that take a deep dive into some of the key developments taking place in the Pharmaceutical and Lifesciences sector in our country. Dr. Milind also provides an insight into the proactive role being played by the government in encouraging the fast-paced development of this sector.

Will the UCPMP 2024 ensure transparency in pharmaceutical practices? Varsha Rajesh, Pharmaceutical and Life Sciences lawyer, Nishith Desai Associates, talks about the granular details of the UCPMP 2024 with PT Jyothi Datta, in this State of the Economy podcast.

In this episode, Dr. Milind Antani, Darren Punnen, Eshika Phadke and Varsha Rajesh provide an overview of the product liability regime in India, the regulator tasked with enforcing it, and what the industry needs to be aware of before launching a product in India.

In this episode, Dr. Milind Antani, Darren Punnen, Eshika Phadke and Varsha Rajesh discuss the interplay of product liability under the regulatory framework for medical devices and the consumer protection law, the concepts of product liability for healthcare service providers, and the documentation practices that medical devices companies should follow for products in the Indian market.

In the first episode of this two-part series, Dr. Milind Antani, Darren Punnen and Eshika Phadke discuss the Drugs (Price Control) Order, 2013 which regulates the price of drugs and medical devices in India, and what companies need to be cognisant of to avoid pitfalls.

In the second episode of this two-part series, Dr. Milind Antani, Darren Punnen and Varsha Rajesh discuss recent developments to the price control regime for medical devices and pharmaceutical companies in India.

Introduction by Dr. Milind Antani of practice and sector and overview of podcasts that would follow

Darren Punnen gives a complete overview of the regulatory framework governing drugs and medical devices in India

Shreya Shenolikar takes us through the history of drug advertising in India, how its regulated and what improvements should be brought in.

Shreya Shenolikar gives and overview of the how drugs and medical devices are regulated across the supply chain covering drug development, clinical trials, manufacture, import and sale.

Darren Punnen takes us through how prices for drugs and medical devices are controlled in India, its various mechanisms, and who gets covered.

Darren Punnen talks about the laws and guidelines regulating the interaction of pharmaceutical and medical device companies with healthcare practitioners, and what to watch out for.

Shreya Shenolikar talks about the importance of trademarks in the pharmaceutical sector and some protections offered under law to trademark holders.

Shreya Shenolikar gives an overview of the patent regime in India and discusses some of the prominent issues in the world of pharmaceutical patenting.

Darren Punnen discusses the emerging trends of online pharmacies and telemedicine, the various issues and controversies, and how things will shape up for the industry.

Darren Punnen talks about the upcoming areas of AI and 3D printing, where India is today, and what needs to be done to facilitate the growth of these technologies.

Shreya Shenolikar analyses how healthcare policy is formed, the hurdles in implementing universal healthcare in India and how we see this space growing in the future.